Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Drug Manufacturers - Specialty & Generic

Healthcare
$6.57 -1.07%

-$0.06 today

Market cap
$98.52M
Beta
0.10
P/E (TTM)
-11.5
EPS (TTM)
-$0.48
52W Low $1.85High $6.61

Volume 0.16M

Average 0.97M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$4.93M

FY 2025 · Annual

Investing Cash Flow

-$4.71M

FY 2025 · Annual

Financing Cash Flow

-$6.75M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(3.6M)(5.65M)(6.28M)(6.48M)(2.86M)
Depreciation & Amortization4.61M5.33M5.77M6.04M5.29M
Deferred Income Tax(192.82K)0000
Stock-Based Compensation741.87K447.5K365.04K301.9K408.32K
Change in Working Capital8.18M10.97M4.63M1.29M2.16M
Accounts Receivables5.5M(6.12M)3.4M(1.94M)(5.24M)
Inventory4.82M1.38M(23.14K)2.41M2.24M
Accounts Payables(757.59K)15.07M3.72M(991.36K)6.71M
Other Working Capital(1.38M)644.92K(2.47M)1.82M(1.55M)
Other Non-Cash Items(3.39M)(2.64M)1.6M(1.77M)(59.95K)
Operating Cash Flow6.34M8.45M6.09M(612.19K)4.93M
Capital Expenditures(354.46K)(2.07M)(453.05K)(179.71K)(97.9K)
Acquisitions (Net)0(13.5M)000
Purchases of Investments(200K)000(4.48M)
Sales of Investments00000
Other Investing Activities52.57K1.9M347.36K237.56K(47K)
Investing Cash Flow(501.89K)(13.67M)(105.7K)57.84K(4.71M)
Debt Repayment01.2M(3.42M)2.49M(10.04M)
Common Stock Issued00005.27M
Common Stock Repurchased(1.39M)(1.05M)(740.53K)(579.05K)(263.48K)
Dividends Paid00000
Other Financing Activities(2.17M)(2.21M)(3.27M)(1.72M)(1.71M)
Financing Cash Flow(3.55M)(2.06M)(7.42M)196.9K(6.75M)
Effect of Forex Changes00000
Net Change in Cash2.29M(7.28M)(1.44M)(357.44K)(6.52M)
Free Cash Flow5.99M6.38M5.64M(791.9K)4.83M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$2.9M
+ D&A$5.3M
+ Stock-Based Comp$408.3K
+ Deferred Tax$0
+ Working Capital$2.2M
- Other Non-Cash-$60.0K
= Operating Cash Flow$4.9M
- Capex-$97.9K
= Free Cash Flow$4.8M

Analysis

FY2025 free cash flow is $4.8M. FCF conversion is -168.8% of net income. Operating cash flow was $4.9M, with capex of -$97.9K. The largest bridge item is D&A at $5.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
8-KCurrent reportNov 10, 2026
8-KCurrent reportOct 26, 2026
8-KCurrent reportOct 23, 2026
8-K/A8-K/A filingSep 11, 2026

Does CPIX generate free cash flow?

Cumberland Pharmaceuticals Inc. (CPIX) generated $4.83M of free cash flow in fiscal 2025.

How much operating cash flow does CPIX produce?

Operating cash flow was $4.93M, before capital expenditures of $97,902.00.